Vasculitis

Long-Term Rituximab Linked to Reduced Incidence of ANCA-Associated Vasculitis

Publish Date June 12, 2020

Extended therapy with rituximab is associated with a reduced incidence of antineutrophil cytoplasmic antibody-associated vasculitis relapse in GPA or MPA.

Avacopan May Be Safe, Efficacious, and Superior to Other Treatments in ANCA-Associated Vasculitis

Publish Date June 5, 2020

Researchers evaluated the efficacy and safety of avacopan for the treatment of ANCA-associated vasculitis.

The Autoimmune COVID-19 Project: A Patient-Centered Initiative

Publish Date May 29, 2020

Study leads Shilpa Venkatachalam, MD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.

Ocular Complications Common Across Spectrum of Rheumatic Diseases

Publish Date May 19, 2020

Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.

Omalizumab Demonstrates Effectiveness in Normocomplementemic Urticarial Vasculitis

Publish Date May 8, 2020

Investigators characterized the effects and markers of response of omalizumab in normocomplementemic urticarial vasculitis.

PEXIVAS Trial Challenges the Benefits of Plasma Exchange, Glucocorticoid Use in ANCA-Associated Vasculitis

Publish Date April 22, 2020

Researchers in the PEXIVAS trial evaluated and challenged the effect of plasma exchange and glucocorticoid use in ANCA-associated vasculitis.

Expert Consensus Guidelines for Remission Maintenance With Rituximab in ANCA-Associated Vasculitis

Publish Date March 31, 2020

An expert panel of clinicians developed guidelines for the use of rituximab in the maintenance of remission for adult ANCA-associated vasculitis.

Alemtuzumab Treatment for Multiple Sclerosis May Induce Life-Threatening ANCA-Associated Vasculitis

Publish Date March 23, 2020

A recent case report examined the adverse effects of alemtuzumab in a patient with relapsing remitting multiple sclerosis.

Plasma Exchange Not Associated With Reduced Incidence of End-Stage Kidney Disease or Death in ANCA Vasculitis

Publish Date March 3, 2020

Researchers compared the efficacy of plasma exchange vs no plasma exchange, in terms of end-stage kidney disease or death, in patients with severe ANCA-associated vasculitis.

Reslizumab Associated With Significant Reduction in Corticosteroid Use in Eosinophilic Granulomatosis With Polyangiitis

Publish Date February 28, 2020

Researchers reported on the outcomes of treatment-refractory, corticosteroid-dependent patients with eosinophilic granulomatosis with polyangiitis with severe asthma.